·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ °ø´Ü, ³ëÀοä¾çº¸Çè Á¤º¸½Ã½ºÅÛ ±¸Ãà ±â»çÀÔ·Â : 07.06.09 07:35:27 0 °¡ ÇÃÄ£Ãß°¡ ±¹¹Î¡¤»ç¾÷ÀÚ °ü¸®¿î¿µ µî È¿À²Àû Áö¿ø '¸ñÇ¥' °Ç°º¸Çè°ø´Ü(ÀÌ»çÀå ÀÌÀç¿ë)ÀÌ ³»³â 8¿ù ³ëÀοä¾çº¸Çè ½ÃÇàÀ» ¾ÕµÎ°í Á¦¹Ý¾÷¹«¸¦ È¿À²ÀûÀ¸·Î Áö¿øÇÏ´Â Á¤º¸½Ã½ºÅÛ ±¸Ãà¿¡ ³ª¼±´Ù. 8ÀÏ °ø´ÜÀº Á¤º¸½Ã½ºÅÛ±¸Ãà »ç¾÷°èȹ(¾È)À» ÅëÇØ "³ëÀÎÀå±â¿ä¾çº¸ÇèÀÇ ¼º°øÀû µµÀÔ¤ýÁ¤ÂøÀ» À§ÇØ Àå±â¿ä¾ç ¼ºñ½ºÀÇ ½Åû, Á¦°ø, Áö¿ø, °ü¸® ¹× °ü·Ã ±â°ü°£ÀÇ Çù·Â¾÷¹«¸¦·Î Áö¿øÇÏ´Â Á¤º¸½Ã½ºÅÛÀ» ±¸ÃàÇÑ´Ù"°í ¹àÇû´Ù. °ø´ÜÀÇ ÀÌ·¯ÇÑ ÆÇ´ÜÀº ½Ã¹ü»ç¾÷À» ÅëÇÑ ÀÚüÁø´Ü °á°ú ÇöÇà ½Ã½ºÅÛÀÌ ¡ãµî±ÞÆÇÁ¤ÀÇ °´°ü¼º Çâ»óÀ» À§ÇÑ ÀÚ·áÈ®º¸ ¡ã¿ä¾ç½Ã¼³ ¿î¿µÇöȲ Á¤º¸Á¦°ø ¡ãÁú °ü¸®¸¦ À§ÇÑ Æò°¡Ã¼°è ¸¶·Ã µî¿¡¼ ´Ù¾çÇÑ ¹®Á¦Á¡À» µå·¯³»°í Àֱ⠶§¹®ÀÌ´Ù. ÀÌ¿¡ °ø´ÜÀº »ç¾÷¾ÈÀ» ÅëÇØ ³ëÀΰ¡Á· ºÎ¾çºÎ´ã °æ°¨ ¹× °ø´Ü °ü¸®¿î¿µÀÇ È¿À²¼ºÀ» Ãß±¸ÇÒ ¼ö ÀÖ´Â »õ·Î¿î Á¤º¸½Ã½ºÅÛÀ» ±¸ÃàÇÑ´Ù´Â °èȹÀÌ´Ù. °ø´ÜÀº "¿ù Çѵµ¾× Á¤µµ°ü¸®, ¿ä¾ç°èȹ ÀûÁ¤¼º ¹× ¼öÁذü¸®, ½É»ç ¹× Áö±ÞÀýÂ÷ µî ¼ºñ½º °ø±ÞÀÚ ¿¬°è °ü¸®È®¸³ µîÀÌ ÀÌ·ïÁú °Í"À̶ó¸ç "±¹¹Î°ú ½Ã¼³¿î¿µÀÚÀÇ ¾÷¹« Á¢±Ù¼ºÀÌ ¿ëÀÌÇÑ ÃֽŠÁ¤º¸½Ã½ºÅÛÀ» ¸¶·ÃÇÒ °Í"À̶ó°í °Á¶Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ ¹Úµ¿ÁØ ±âÀÚ(pdj30@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °ø´Ü, ³ëÀοä¾çº¸Çè Á¤º¸½Ã½ºÅÛ ±¸Ãà URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °ø´Ü, ³ëÀοä¾çº¸Çè Á¤º¸½Ã½ºÅÛ ±¸Ãà ±â»çÀÔ·Â : 07.06.09 07:35:27 0 °¡ ÇÃÄ£Ãß°¡ ±¹¹Î¡¤»ç¾÷ÀÚ °ü¸®¿î¿µ µî È¿À²Àû Áö¿ø '¸ñÇ¥' °Ç°º¸Çè°ø´Ü(ÀÌ»çÀå ÀÌÀç¿ë)ÀÌ ³»³â 8¿ù ³ëÀοä¾çº¸Çè ½ÃÇàÀ» ¾ÕµÎ°í Á¦¹Ý¾÷¹«¸¦ È¿À²ÀûÀ¸·Î Áö¿øÇÏ´Â Á¤º¸½Ã½ºÅÛ ±¸Ãà¿¡ ³ª¼±´Ù. 8ÀÏ °ø´ÜÀº Á¤º¸½Ã½ºÅÛ±¸Ãà »ç¾÷°èȹ(¾È)À» ÅëÇØ "³ëÀÎÀå±â¿ä¾çº¸ÇèÀÇ ¼º°øÀû µµÀÔ¤ýÁ¤ÂøÀ» À§ÇØ Àå±â¿ä¾ç ¼ºñ½ºÀÇ ½Åû, Á¦°ø, Áö¿ø, °ü¸® ¹× °ü·Ã ±â°ü°£ÀÇ Çù·Â¾÷¹«¸¦·Î Áö¿øÇÏ´Â Á¤º¸½Ã½ºÅÛÀ» ±¸ÃàÇÑ´Ù"°í ¹àÇû´Ù. °ø´ÜÀÇ ÀÌ·¯ÇÑ ÆÇ´ÜÀº ½Ã¹ü»ç¾÷À» ÅëÇÑ ÀÚüÁø´Ü °á°ú ÇöÇà ½Ã½ºÅÛÀÌ ¡ãµî±ÞÆÇÁ¤ÀÇ °´°ü¼º Çâ»óÀ» À§ÇÑ ÀÚ·áÈ®º¸ ¡ã¿ä¾ç½Ã¼³ ¿î¿µÇöȲ Á¤º¸Á¦°ø ¡ãÁú °ü¸®¸¦ À§ÇÑ Æò°¡Ã¼°è ¸¶·Ã µî¿¡¼ ´Ù¾çÇÑ ¹®Á¦Á¡À» µå·¯³»°í Àֱ⠶§¹®ÀÌ´Ù. ÀÌ¿¡ °ø´ÜÀº »ç¾÷¾ÈÀ» ÅëÇØ ³ëÀΰ¡Á· ºÎ¾çºÎ´ã °æ°¨ ¹× °ø´Ü °ü¸®¿î¿µÀÇ È¿À²¼ºÀ» Ãß±¸ÇÒ ¼ö ÀÖ´Â »õ·Î¿î Á¤º¸½Ã½ºÅÛÀ» ±¸ÃàÇÑ´Ù´Â °èȹÀÌ´Ù. °ø´ÜÀº "¿ù Çѵµ¾× Á¤µµ°ü¸®, ¿ä¾ç°èȹ ÀûÁ¤¼º ¹× ¼öÁذü¸®, ½É»ç ¹× Áö±ÞÀýÂ÷ µî ¼ºñ½º °ø±ÞÀÚ ¿¬°è °ü¸®È®¸³ µîÀÌ ÀÌ·ïÁú °Í"À̶ó¸ç "±¹¹Î°ú ½Ã¼³¿î¿µÀÚÀÇ ¾÷¹« Á¢±Ù¼ºÀÌ ¿ëÀÌÇÑ ÃֽŠÁ¤º¸½Ã½ºÅÛÀ» ¸¶·ÃÇÒ °Í"À̶ó°í °Á¶Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ ¹Úµ¿ÁØ ±âÀÚ(pdj30@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °ø´Ü, ³ëÀοä¾çº¸Çè Á¤º¸½Ã½ºÅÛ ±¸Ãà URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °ø´Ü, ³ëÀοä¾çº¸Çè Á¤º¸½Ã½ºÅÛ ±¸Ãà ±â»çÀÔ·Â : 07.06.09 07:35:27 0 °¡ ÇÃÄ£Ãß°¡ ±¹¹Î¡¤»ç¾÷ÀÚ °ü¸®¿î¿µ µî È¿À²Àû Áö¿ø '¸ñÇ¥' °Ç°º¸Çè°ø´Ü(ÀÌ»çÀå ÀÌÀç¿ë)ÀÌ ³»³â 8¿ù ³ëÀοä¾çº¸Çè ½ÃÇàÀ» ¾ÕµÎ°í Á¦¹Ý¾÷¹«¸¦ È¿À²ÀûÀ¸·Î Áö¿øÇÏ´Â Á¤º¸½Ã½ºÅÛ ±¸Ãà¿¡ ³ª¼±´Ù. 8ÀÏ °ø´ÜÀº Á¤º¸½Ã½ºÅÛ±¸Ãà »ç¾÷°èȹ(¾È)À» ÅëÇØ "³ëÀÎÀå±â¿ä¾çº¸ÇèÀÇ ¼º°øÀû µµÀÔ¤ýÁ¤ÂøÀ» À§ÇØ Àå±â¿ä¾ç ¼ºñ½ºÀÇ ½Åû, Á¦°ø, Áö¿ø, °ü¸® ¹× °ü·Ã ±â°ü°£ÀÇ Çù·Â¾÷¹«¸¦·Î Áö¿øÇÏ´Â Á¤º¸½Ã½ºÅÛÀ» ±¸ÃàÇÑ´Ù"°í ¹àÇû´Ù. °ø´ÜÀÇ ÀÌ·¯ÇÑ ÆÇ´ÜÀº ½Ã¹ü»ç¾÷À» ÅëÇÑ ÀÚüÁø´Ü °á°ú ÇöÇà ½Ã½ºÅÛÀÌ ¡ãµî±ÞÆÇÁ¤ÀÇ °´°ü¼º Çâ»óÀ» À§ÇÑ ÀÚ·áÈ®º¸ ¡ã¿ä¾ç½Ã¼³ ¿î¿µÇöȲ Á¤º¸Á¦°ø ¡ãÁú °ü¸®¸¦ À§ÇÑ Æò°¡Ã¼°è ¸¶·Ã µî¿¡¼ ´Ù¾çÇÑ ¹®Á¦Á¡À» µå·¯³»°í Àֱ⠶§¹®ÀÌ´Ù. ÀÌ¿¡ °ø´ÜÀº »ç¾÷¾ÈÀ» ÅëÇØ ³ëÀΰ¡Á· ºÎ¾çºÎ´ã °æ°¨ ¹× °ø´Ü °ü¸®¿î¿µÀÇ È¿À²¼ºÀ» Ãß±¸ÇÒ ¼ö ÀÖ´Â »õ·Î¿î Á¤º¸½Ã½ºÅÛÀ» ±¸ÃàÇÑ´Ù´Â °èȹÀÌ´Ù. °ø´ÜÀº "¿ù Çѵµ¾× Á¤µµ°ü¸®, ¿ä¾ç°èȹ ÀûÁ¤¼º ¹× ¼öÁذü¸®, ½É»ç ¹× Áö±ÞÀýÂ÷ µî ¼ºñ½º °ø±ÞÀÚ ¿¬°è °ü¸®È®¸³ µîÀÌ ÀÌ·ïÁú °Í"À̶ó¸ç "±¹¹Î°ú ½Ã¼³¿î¿µÀÚÀÇ ¾÷¹« Á¢±Ù¼ºÀÌ ¿ëÀÌÇÑ ÃֽŠÁ¤º¸½Ã½ºÅÛÀ» ¸¶·ÃÇÒ °Í"À̶ó°í °Á¶Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ ¹Úµ¿ÁØ ±âÀÚ(pdj30@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °ø´Ü, ³ëÀοä¾çº¸Çè Á¤º¸½Ã½ºÅÛ ±¸Ãà URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö